FN1 and cancer: Repeating the experiment using CT-CD11b+-cells differentiated in the presence of EDA-FN with and without an inhibitor of α5β1 revealed that inhibiting α5β1 for 24 h in differentiating CD11b+-cells was enough to suppress cancer growth (Fig 9C).